LEDDA, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 175
EU - Europa 105
AS - Asia 56
Totale 336
Nazione #
US - Stati Uniti d'America 174
IT - Italia 38
IE - Irlanda 30
SG - Singapore 28
SE - Svezia 15
CN - Cina 12
GB - Regno Unito 8
FI - Finlandia 4
HK - Hong Kong 4
VN - Vietnam 4
DE - Germania 3
KR - Corea 3
BE - Belgio 2
IN - India 2
AT - Austria 1
BN - Brunei Darussalam 1
DK - Danimarca 1
FR - Francia 1
HN - Honduras 1
NL - Olanda 1
PH - Filippine 1
PL - Polonia 1
TW - Taiwan 1
Totale 336
Città #
Chandler 52
Dublin 30
Singapore 22
Nyköping 14
Turin 10
Genoa 8
Medford 8
Ashburn 6
Milan 6
Princeton 5
Torino 5
Hangzhou 4
West Jordan 4
Wilmington 4
Beijing 3
Hebei 3
Helsinki 3
Chengdu 2
Cuneo 2
Delhi 2
Fairfield 2
Hong Kong 2
London 2
New York 2
Norwalk 2
Seoul 2
Upper Marlboro 2
Amsterdam 1
Bandar Seri Begawan 1
Brabrand 1
Brussels 1
Chicago 1
Cologne 1
Dallas 1
Gaimersheim 1
Houston 1
Jacksonville 1
Kiel 1
Lappeenranta 1
Liverpool 1
Los Angeles 1
Malmö 1
Manila 1
Ormond Beach 1
San Diego 1
Schoten 1
Seodaemun-gu 1
Southwark 1
Taipei City 1
Tegucigalpa 1
Victoria 1
Vienna 1
Warsaw 1
Totale 233
Nome #
COVID-19 and Parkinson's Disease: What We Know So Far? 57
Motor and non-motor outcomes of subthalamic deep brain stimulation in a case of juvenile PARK-PINK1 54
Time to onset and duration of botulinum toxin efficacy in movement disorders 53
Neurological comorbidities and COVID-19-related case fatality: A cohort study 39
G325R GBA mutation in Parkinson's disease: Disease course and long-term DBS outcome 35
Burden of caregiving for cardiovascular dysautonomia in Parkinson's disease 21
SARS-CoV-2 vaccination, Parkinson's disease, and other movement disorders: case series and short literature review 18
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 16
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson’s disease patients 12
The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel 12
How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease 12
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson’s disease patient with Parkin gene mutation: a case report 11
Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson's disease 4
Neurological symptoms in adults with Gaucher disease: a systematic review 4
CACNA1A variant associated with generalized dystonia 3
Longitudinal Assessment of Botulinum Toxin Treatment for Lateral Trunk Flexion and Pisa Syndrome in Parkinson's Disease: Real-life, Long-Term Study 2
Incidence and predictors of postural abnormalities in Parkinson's disease: a PPMI cohort study 2
Effects of Continuous Dopaminergic Stimulation on Parkinson's Disease Gait: A Longitudinal Prospective Study with Levodopa Intestinal Gel Infusion 2
Totale 357
Categoria #
all - tutte 2.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 1 2 3 11
2021/202266 1 3 3 3 3 2 1 2 6 1 24 17
2022/2023152 14 19 3 15 11 36 10 7 10 10 9 8
2023/2024100 9 14 2 2 7 20 1 1 1 17 5 21
2024/202522 12 10 0 0 0 0 0 0 0 0 0 0
Totale 357